Lataa...
Predicting the biodistribution of radiolabeled cMORF effector in MORF-pretargeted mice
Pretargeting with phosphorodiamidate morpholino oligomers (MORFs) involves a MORF-conjugated anti-tumor antibody such as MN14 as pretargeting agent administered before that of the radiolabeled complementary MORF (cMORF) as the effector. The dosages of the pretargeting agent and effector, the pretarg...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2007
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1808331/ https://ncbi.nlm.nih.gov/pubmed/17021815 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-006-0222-3 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|